英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
HI TOPK 032
|
487020-03-1 |
1085563
|
|
C20H11N5OS |
369.39924 | |
Clindamycin hydrochloride
|
21462-39-5 |
盐酸克林霉素
|
克林霉素盐酸盐;林大霉素;氯林可霉素;盐酸氯洁霉素;盐酸克林霉素;盐酸克林霉素(标准品);7-氯-6,7,8-三脱氧-6-[[[(2S,4R)-1-甲基-4-丙基-2-吡咯烷基]羰基]氨基]-1-硫代甲基-L-苏-Α-D-吡喃半乳糖苷盐酸盐;盐酸克林霉素(氯洁霉素)
|
C18H34Cl2N2O5S |
461.44 | 244-398-6 |
AP24534 (Ponatinib)
|
943319-70-8 |
帕纳替尼
|
AP-24534;AP 24534;AP24534;PONATINIB;3-(IMIDAZO[1,2-B]PYRIDAZIN-3-YLETHYNYL)-4-METHYL-N-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-(TRIFLUOROMETHYL)PHENYL)BENZAMIDE;CS-165;普纳替尼杂质;3-(2-咪唑并[1,2-B]哒嗪-3-乙炔基)-4-甲基-N-[4-[(4-甲基-1-哌嗪基)甲基]-3-(三氟甲基)苯基]苯甲酰胺;帕纳替尼PONATINIB;泊那替尼;帕纳替尼
|
C29H27F3N6O |
532.22 | 1308068-626-2 |
TG 100713
|
925705-73-3 |
TG 1713,3-(2,4-DIAMINO-6-PTERIDINYL)-PHENOL
|
TG100713;TG 100713;CS-577;TG100110
|
C12H10N6O |
254.2474 | |
Amitriptyline Hydrochloride
|
549-18-8 |
盐酸阿米替林
|
N,N-二甲基-3-[10,11-二氢-5H-二苯并(a,b)环庚三烯-5-亚基]-1-丙胺盐酸盐;盐酸阿米替林;阿米替林盐酸盐;盐酸阿米替林(2-8°C);阿米替林 盐酸盐 溶液;盐酸阿米替林(标准品);盐酸阿米替林(CAS号:549-18-9);阿密替林
|
C20H23N.HCL |
313.87 | 208-964-6 |
PF-04457845
|
1020315-31-4 |
N-哒嗪-3-基-4-(3-{[5-(三氟甲基)吡啶-2-基]醚}苯亚甲基丙酮)哌啶-1-羧酰胺
|
N-哒嗪-3-基-4-(3-{[5-(三氟甲基)吡啶-2-基]醚}苯亚甲基丙酮)哌啶-1-羧酰胺
|
C23H20F3N5O2 |
455.43241 | |
Methylmalonic Acid
|
516-05-2 |
甲基丙二酸
|
甲基丙二酸;甲基马来酸;異琥珀酸;2-甲基丙二酸;甲基丙二酸 溶液
|
C4H6O4 |
118.09 | 208-219-5 |
TDZD-8
|
327036-89-5 |
4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE
|
4-苄基-2-甲基-1,2,4-噻二唑烷-3,5-二酮;4-苯甲基-2-甲基-1,5-二酮
|
C10H10N2O2S1 |
222.26 | |
Olanzapine
|
132539-06-1 |
奥氮平
|
苯磺酸氨氯地平;2-甲基-4-(4-甲基-1-哌嗪基)-10H-噻吩并[2,3-B][1,5]苯并二氮杂卓;OLANZAPINE奥氮平原料;奥氮平(CAS号:132539-06-1);鈦穄TETRADECA-1(14),3(7),5,8,10,12-HEXAENE;奥氮平D8;奥氮平,一种5-HT2和D2受体高亲和性拮抗剂;2-甲基-10-(4-甲基-1-哌嗪)-4H-噻吩并[2,6] 苯并二氮杂;奥氮平(标准品)
|
C20H25ClN2O5.C6H6O3S;C17H20N4S |
312.43 | |
PFI-1 (PF-6405761)
|
1403764-72-6 |
PFI-1 (PF-645761)
|
2-甲氧基-N-(3-甲基-2-氧代-1,2,3,4-四氢喹唑啉-6-基)苯磺酰胺;PFI-1;PFI-1;PFI 1;PFI1;CS-709;PFI 1;PFI1
|
C16H17N3O4S |
347.4 | |
NBD-556
|
333353-44-9 |
N-(4-氯苯基)-N'-(2,2,6,6-四甲基哌啶-4-基)草酰胺
|
N-(4-氯苯基)-N'-(2,2,6,6-四甲基哌啶-4-基)草酰胺;NBD-556;NBD 556;NBD556
|
C17H24ClN3O2 |
337.84436 | |
Phosphoramidon Disodium Salt
|
164204-38-0 |
16424-38-
|
|
C23H34N3Na2O10P |
589.483 | |
LY2603618 (IC-83)
|
911222-45-2 |
N-[5-溴-4-甲基-2-[(2S)-2-吗啉甲氧基]苯基]-N'-(5-甲基-2-吡嗪基)脲
|
RABUSERTIB;IC-83;IC-83;LY 2603618;LY-2603618;CS-508;N-[5-溴-4-甲基-2-[(2S)-2-吗啉甲氧基]苯基]-N'-(5-甲基-2-吡嗪基)脲
|
C18H22BrN5O3 |
436.32 | |
PF 06273340
|
1402438-74-7 |
N-[5-[2-AMINO-7-(1-HYDROXY-2-METHYLPROPAN-2-YL)PYRROLO[2,3-D]PYRIMIDINE-5-CARBONYL]PYRIDIN-3-YL]-2-(5-CHLOROPYRIDIN-2-YL)ACETAMIDE
|
N-[5-[2-AMINO-7-(1-HYDROXY-2-METHYLPROPAN-2-YL)PYRROLO[2,3-D]PYRIMIDINE-5-CARBONYL]PYRIDIN-3-YL]-2-(5-CHLOROPYRIDIN-2-YL)ACETAMIDE
|
C23H22ClN7O3 |
479.91888 | |
SNS-032 (BMS-387032)
|
345627-80-7 |
N-[5-[(5-叔丁基-1,3-恶唑-2-基)甲硫基]-1,3-噻唑-2-基]哌啶-4-甲酰胺
|
BMS-387032;SNS 032;SNS032;BMS 387032;BMS387032;CS-202;N-[5-[(5-叔丁基-1,3-恶唑-2-基)甲硫基]-1,3-噻唑-2-基]哌啶-4-甲酰胺;N-(5-((5-叔丁基噁唑-2-基)甲基硫基)噻唑-2-基)哌啶-4-甲酰胺;SNS-032,一种选择性CDK2抑制剂
|
C17H24N4O2S2 |
380.53 | |
AGN 193109
|
171746-21-7 |
4-[2-[5,6-二氢-5,5-二甲基-8-(4-甲基苯基)-2-萘基]乙炔基]苯甲酸
|
4-[2-[5,6-二氢-5,5-二甲基-8-(4-甲基苯基)-2-萘基]乙炔基]苯甲酸
|
C28H24O2 |
392.496 | |
lonafarnib
|
193275-84-2 |
4-[2-[4-[(11R)-3,1-二溴-8-氯-6,11-二氢-5H-苯并[5,6]环庚并[1,2-B]吡啶-11-基]-1-哌啶基]-2-氧代乙基]-1-哌啶甲酰胺
|
SARASAR;SCH 66336;SCH66336;SCH-66336;4-[2-[4-[(11R)-3,10-二溴-8-氯-6,11-二氢-5H-苯并[5,6]环庚并[1,2-B]吡啶-11-基]-1-哌啶基]-2-氧代乙基]-2-哌啶甲酰胺;洛那法尼;洛那法尼(抗癌类抗白血病药);氯那法尼
|
C27H31Br2ClN4O2 |
638.82 | |
4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol
|
937174-76-0 |
4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇
|
CS-37;4-[2-(4-氨基-1,2,5-恶二唑-3-基)-1-乙基-7-[(3S)-3-哌啶基甲氧基]-1H-咪唑并[4,5-C]吡啶-4-基]-2-甲基-3-丁炔-2-醇;GSK690693;GSK-690693;GSK 690693;GSK 690693;GSK-690693
|
C21H27N7O3 |
425.48 | |
bexarotene
|
153559-49-0 |
蓓萨罗丁
|
蓓萨罗丁(抗癌药);萨罗丁杂质;蓓萨罗丁(标准品);4-[1-(5,6,7,8-四氢-3,5,8,8-五甲基-2-萘基)乙烯基]苯甲酸;蓓萨罗丁;蓓萨罗丁(贝沙罗丁);蓓萨罗丁(4-[1-(5,8-五甲基-3-萘基)乙烯基]苯甲酸)
|
C24H28O2 |
348.48 | |
Medetomidine hydrochloride
|
86347-15-1 |
盐酸美托咪啶
|
(R)-4-[1-(2,3-二甲基苯基)乙基]-1H-咪唑盐酸盐;盐酸美托咪啶;5-[1-(2,3-二甲基苯基)乙基]-1H-咪唑盐酸盐;盐酸美托嘧啶;盐酸美托咪定;盐酸咪托咪定;美托咪定盐酸盐;3-二甲基苯基)乙基]-1H-咪唑盐酸盐
|
C13H16N2.HCl |
236.74 | 645-306-0 |